• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Class 2 Device Recall Perkin Elmer

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
 Class 2 Device Recall Perkin Elmersee related information
Date Initiated by FirmMarch 11, 2005
Date PostedJune 09, 2005
Recall Status1 Terminated 3 on November 21, 2005
Recall NumberZ-0879-05
Recall Event ID 31703
Product Classification System, Test, Amino Acids, Free Carnitines And Acylcarnitines Tandem Mass Spectrometry - Product Code NQL
ProductPerkin ELmer Life and Analytical Sciences -NeoGram Amino Acids and Acylcarnitines Tandem Mass Spectrometry Kit
Code Information Catalog Number: MS-8970 Lot numbers: 252208, 257031, 258928, 258937, 259588, 263097, 267166 , 267628, 268256, 268258, 268403, 268404, 268675  
Recalling Firm/
Manufacturer
Perkin Elmer Life And Analytical
331 Treble Cove Rd
North Billerica MA 01862-2849
Manufacturer Reason
for Recall
Pump failure may effect data integrity
FDA Determined
Cause 2
Other
ActionPerkin Elmer notified US Customers by letter on 3/11/05. Instructions were provided to service engineers for preventative maintenance. During the week of 5/5/05, the firm is issuing a recall letter recalling the solvents and solutions of these kits. The firm will send a Service Engineer to oversee destruction and maintenance of the pump.
Quantity in Commerce622 kits
DistributionAL, CA, CT, FL, IN, LA, GA, MI, MO, NJ, OR,SC
Total Product Life CycleTPLC Device Report

1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
-
-